Terms: = Thyroid cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR
21 results:
1. Identification of the communal pathogenesis and immune landscape between viral myocarditis and dilated cardiomyopathy.
Lei Z; Cao J; Wu J; Lu Y; Ni L; Hu X
ESC Heart Fail; 2024 Feb; 11(1):282-292. PubMed ID: 37967839
[TBL] [Abstract] [Full Text] [Related]
2. Cytochalasin Q exerts anti-melanoma effect by inhibiting creatine kinase B.
Lu Y; Zhang P; Chen H; Tong Q; Wang J; Li Q; Tian C; Yang J; Li S; Zhang Z; Yuan H; Xiang M
Toxicol Appl Pharmacol; 2022 Apr; 441():115971. PubMed ID: 35276125
[TBL] [Abstract] [Full Text] [Related]
3. miR-183-5p promotes proliferation, invasion, and glycolysis of thyroid carcinoma cells by targeting foxo1.
Han C; Mo K; Jiang L; Wang K; Teng L
Mol Cell Biochem; 2022 Apr; 477(4):1195-1206. PubMed ID: 35084673
[TBL] [Abstract] [Full Text] [Related]
4. Inhibition of glioblastoma progression by Urolithin A in vitro and in vivo by regulating Sirt1-foxo1 axis via ERK/AKT signaling pathways.
Liu CL; Zhao D; Li JJ; Liu S; An JJ; Wang D; Hu FA; Qiu CY; Cui MH
Neoplasma; 2022 Jan; 69(1):80-94. PubMed ID: 34818027
[TBL] [Abstract] [Full Text] [Related]
5. Artesunate inhibits proliferation, migration, and invasion of thyroid cancer cells by regulating the PI3K/AKT/fkhr pathway.
Xu Z; Liu X; Zhuang D
Biochem Cell Biol; 2022 Feb; 100(1):85-92. PubMed ID: 34797728
[TBL] [Abstract] [Full Text] [Related]
6. Luteolin-Loading Her-2 Nanospheres Enhances Targeting and Therapeutic Effects of Breast cancer.
Xiao C; Wang X; Shen J; Xia Y; Qiu S; Liang X; Gu W
J Biomed Nanotechnol; 2021 Aug; 17(8):1545-1553. PubMed ID: 34544532
[TBL] [Abstract] [Full Text] [Related]
7. Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human thyroid Carcinoma Cell Line.
Nozhat Z; Zarkesh M; Baldini E; Mohammadi-Yeganeh S; Azizi F; Hedayati M
Anticancer Agents Med Chem; 2022; 22(4):713-720. PubMed ID: 33461474
[TBL] [Abstract] [Full Text] [Related]
8. KCTD12 promotes G1/S transition of breast cancer cell through activating the AKT/foxo1 signaling.
Ye RY; Kuang XY; Zeng HJ; Shao N; Lin Y; Wang SM
J Clin Lab Anal; 2020 Aug; 34(8):e23315. PubMed ID: 32207860
[TBL] [Abstract] [Full Text] [Related]
9. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/foxo1 axis in papillary thyroid carcinoma.
Feng Z; Chen R; Huang N; Luo C
Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
[TBL] [Abstract] [Full Text] [Related]
10. Effects of metformin on the PI3K/AKT/foxo1 pathway in anaplastic thyroid cancer cell lines.
Nozhat Z; Mohammadi-Yeganeh S; Azizi F; Zarkesh M; Hedayati M
Daru; 2018 Dec; 26(2):93-103. PubMed ID: 30242671
[TBL] [Abstract] [Full Text] [Related]
11. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract] [Full Text] [Related]
13. DNA Mismatch Repair Deficiency Promotes Genomic Instability in a Subset of Papillary thyroid cancers.
Javid M; Sasanakietkul T; Nicolson NG; Gibson CE; Callender GG; Korah R; Carling T
World J Surg; 2018 Feb; 42(2):358-366. PubMed ID: 29075860
[TBL] [Abstract] [Full Text] [Related]
14. Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of foxo1 and Bim pathway.
Chi HC; Chen SL; Cheng YH; Lin TK; Tsai CY; Tsai MM; Lin YH; Huang YH; Lin KH
Cell Death Dis; 2016 Aug; 7(8):e2324. PubMed ID: 27490929
[TBL] [Abstract] [Full Text] [Related]
15. The Transcriptional Regulation of FOXO Genes in Thyrocytes.
Franz F; Weidinger C; Krause K; Gimm O; Dralle H; Führer D
Horm Metab Res; 2016 Sep; 48(9):601-6. PubMed ID: 27258970
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-96 plays an oncogenic role by targeting foxo1 and regulating AKT/foxo1/Bim pathway in papillary thyroid carcinoma cells.
Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
[TBL] [Abstract] [Full Text] [Related]
17. Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma.
Liu X; He M; Hou Y; Liang B; Zhao L; Ma S; Yu Y; Liu X
Oncol Rep; 2013 Apr; 29(4):1415-20. PubMed ID: 23380809
[TBL] [Abstract] [Full Text] [Related]
18. foxo1 controls thyroid cell proliferation in response to TSH and IGF-I and is involved in thyroid tumorigenesis.
Zaballos MA; Santisteban P
Mol Endocrinol; 2013 Jan; 27(1):50-62. PubMed ID: 23160481
[TBL] [Abstract] [Full Text] [Related]
19. XB130 mediates cancer cell proliferation and survival through multiple signaling events downstream of Akt.
Shiozaki A; Shen-Tu G; Bai X; Iitaka D; De Falco V; Santoro M; Keshavjee S; Liu M
PLoS One; 2012; 7(8):e43646. PubMed ID: 22928011
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of histological and immunohistochemical characteristics for predicting the recurrence of medullary thyroid carcinoma.
Ríos A; Rodríguez JM; Acosta JM; Balsalobre MD; Torregrosa N; Sola J; Pérez-Flores D; Parrilla P
Ann Surg Oncol; 2010 Sep; 17(9):2444-51. PubMed ID: 20224859
[TBL] [Abstract] [Full Text] [Related]
[Next]
